Metabolon, Inc., a technology company, develops analytical methods and software for biomarker discovery using metabolomics. It offers biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. The company provides biochemical markers and information for understanding biochemical processes, such as drug action, toxicology, and bioprocess monitoring. Its metabolomics platform is used to develop diagnostics for cancer, amyotropic lateral sclerosis, diabetes, and metabolic diseases. The company was founded in 2000 and is based in Durham, North Carolina.